Viruses with RNA Genomes
Hepatic Drug Excretion: Influencing Factors
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 22, 2026

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
Guanghui Ren1, Kaining Jia2, Sitong Yi1
1Department of Infectious Disease, Liver Disease Center of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Metabolic dysfunction-associated fatty liver disease (MAFLD) may suppress chronic hepatitis B (CHB) viral activity. A novel miR-122/SOX4 pathway is identified as a key regulator in this interaction, offering potential therapeutic targets for liver disease.
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: